Assenagon Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.6M | Sell |
|
|||||
|
2025
Q2 | $42.3M | Buy |
|
|||||
|
2025
Q1 | $7.82M | Buy |
|
|||||
|
2024
Q4 | $2.91M | Sell |
|
|||||
|
2024
Q3 | $8.08M | Buy |
|
|||||
|
2024
Q2 | $5.84M | Hold |
|
|||||
|
2024
Q1 | $6.64M | Sell |
|
|||||
|
2023
Q4 | $6.82M | Sell |
|
|||||
|
2023
Q3 | $7.52M | Sell |
|
|||||
|
2023
Q2 | $10.8M | Sell |
|
|||||
|
2023
Q1 | $16.6M | Buy |
|
|||||
|
2022
Q4 | $7.4M | Sell |
|
|||||
|
2022
Q3 | $7.83M | Buy |
|
|||||
|
2022
Q2 | $617K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $879K | Buy |
|
|||||
|
2021
Q3 | $821K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $8.29M | Buy |
|